190.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
Krystal Biotech Inc. stock trend forecast2025 Key Lessons & Free Verified High Yield Trade Plans - newser.com
BofA Securities Adjusts Krystal Biotech Price Target to $255 From $182, Maintains Buy Rating - MarketScreener
B of A Securities Raises Price Target for KRYS to $255, Maintains Buy Rating | KRYS Stock News - GuruFocus
Krystal Biotech stock price target raised to $255 from $182 at BofA - Investing.com
Chart based analysis of Krystal Biotech Inc. trendsJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Is Krystal Biotech Inc. stock safe for conservative investors2025 Historical Comparison & Consistent Growth Stock Picks - newser.com
Krystal Biotech Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
What drives Krystal Biotech Inc stock priceMarket Liquidity Analysis & Free Stock Trading Workshops - earlytimes.in
Insider Confidence Shines: Krystal Biotech and Growth Stocks with Strong Management Stakes Navigate Volatile Markets - FinancialContent
Krystal Biotech And 2 More Growth Stocks With Significant Insider Ownership - Yahoo Finance
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation - CGTLive®
Krystal Biotech, Inc. (NASDAQ:KRYS) Looks Just Right With A 31% Price Jump - 富途牛牛
Is Krystal Biotech Inc. stock a safe buy before earningsMarket Trend Summary & Daily Stock Trend Reports - newser.com
Is Krystal Biotech Inc. meeting your algorithmic filter criteriaGlobal Markets & Expert Approved Trade Ideas - newser.com
FDA grants platform technology designation to Krystal Biotech’s HSV-1 vector - Investing.com Canada
FDA grants platform technology designation to Krystal Biotech’s HSV-1 vector By Investing.com - Investing.com South Africa
Krystal Biotech Gets US FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 - MarketScreener
FDA Grants Platform Technology Status to Krystal Biotech's Gene Therapy - GuruFocus
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis - The Manila Times
FDA Platform Designation: Krystal Biotech's HSV‑1 Viral Vector for KB801 to Advance Neurotrophic Keratitis Treatment - Stock Titan
Analyzing Krystal Biotech Inc. with risk reward ratio charts2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
What machine learning models say about Krystal Biotech Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Krystal Biotech (KRYS) Stock Analysis: A 13% Upside Potential Amid Strong Revenue Growth - DirectorsTalk Interviews
What valuation multiples suggest for Krystal Biotech Inc. stock2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Krystal Biotech Inc. stock outlook for YEARJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Will Krystal Biotech Inc. (4KB) stock outperform Dow Jones2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
Is Krystal Biotech Inc 4KB a good long term investmentCandlestick Trading Patterns & Budget Investment Success - earlytimes.in
I See Some Speculative Wins Starting to Krystal-ize - TheStreet Pro
What high frequency data says about Krystal Biotech Inc.2025 Momentum Check & Fast Gain Stock Tips - newser.com
Published on: 2025-10-10 04:55:37 - newser.com
What's Driving the Market Sentiment Around Krystal Biotech Inc? - Sahm
Market Participants Recognise Krystal Biotech, Inc.'s (NASDAQ:KRYS) Earnings Pushing Shares 29% Higher - simplywall.st
Sentiment analysis tools applied to Krystal Biotech Inc.Trade Exit Report & Technical Entry and Exit Alerts - newser.com
How Krystal Biotech Inc. stock reacts to Fed rate cutsCEO Change & AI Forecasted Entry/Exit Points - newser.com
Is Krystal Biotech Inc. (4KB) stock a buy for dividend portfoliosTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com
How Krystal Biotech Inc. (4KB) stock reacts to monetary easingTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Will Krystal Biotech Inc. (4KB) stock see valuation expansionTrend Reversal & Safe Capital Growth Trade Ideas - newser.com
What’s the recovery path for long term holders of Krystal Biotech Inc.Weekly Trading Summary & Community Verified Trade Signals - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):